I challenge you to find a Biotech on the ASX which represents better value than CUV.
ROTFL. Most Companies are listed on the ASX because they can't find anyone to buy their worthless technology. The only thing CUV has actually achieved is getting orphan drug status for a 40 year old drug after 15 years of effort. If you knew anything about the drug approval process you would know orphan drug status isn't hard to obtain.
It seems that most HC 'investors'' actually have absolutely zero formal training or expertise in any of the the technologies they invest in. Many don't even have HSC yet they are self-proclaimed ''experts"' in extremely complex businesses and technologies that probably require a PhD and decades of experience to fully comprehend. They are typically paranoid and accuse of everyone who doesn't have the same starry eyed enthusiasm of being a shorter.
- Forums
- ASX - By Stock
- CUV
- Ann: Media release - First stroke patient with afamelanotide
Ann: Media release - First stroke patient with afamelanotide, page-21
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.68 |
Change
-0.240(1.61%) |
Mkt cap ! $735.1M |
Open | High | Low | Value | Volume |
$14.75 | $14.92 | $14.65 | $503.5K | 34.18K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 448 | $14.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.74 | 149 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 448 | 14.680 |
1 | 340 | 14.600 |
2 | 1069 | 14.560 |
1 | 2000 | 14.520 |
1 | 500 | 14.500 |
Price($) | Vol. | No. |
---|---|---|
14.980 | 1000 | 1 |
15.150 | 519 | 1 |
15.180 | 100 | 1 |
15.190 | 50 | 1 |
15.200 | 47 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |